Janine Reudt-Demont is a life sciences and healthcare specialist at Niederer Kraft Frey. Her experience covers the regulation of all aspects of the medtech and pharmaceutical industry, including clinical trials, product classifications, authorizations, market access, promotion and marketing, compliance (including data privacy questions) as well as transparency and anti-corruption. Janine also advises on regulatory and compliance matters concerning other regulated products such as cosmetics, foodstuffs, tobacco and CBD-products.

Janine further possesses specialist knowledge and experience in all areas of commercial law, with main focus on distribution, franchising, e-commerce as well as product liability and product safety matters (including recalls). She also has an IP background and often advises on licensing, R&D and supply agreements as well as on unfair competition and advertising law.

In addition to her advisory expertise, Janine regularly represents clients in court proceedings, arbitration, mediation and before administrative bodies.

Deals & Cases

L Catterton leads CHF 70m Series B of Planted
Discover More
FEMSA and Valora join forces – Agreement on the acquisition of Valora Holding AG by FEMSA, a leading Latin American retailer by way of public tender cash offer
Discover More
HCL Technologies acquires Confinale
Discover More


Recent matters in which Janine acted include advising/representing:

  • The shareholders of Bahnhof Apotheke Langnau AG, the Swiss pioneer in cannabis formulations and treatments, on the sale of 100% of the shares to Galenica, one of the leading fully-integrated healthcare providers in Switzerland;
  • Various manufacturers and distributors of medical devices on the implementation of the revised regulation on medical devices;
  • One of the largest e-commerce retailers with respect to unfair competition, pricing and advertising;
  • Neurimmune AG, a startup biopharmaceutical company, with respect to clinical studies, data protection and pharma advertising;
  • A Belgian distributor of high-quality pacifiers and baby products on the termination of a long-term distribution contract and in negotiations for a goodwill compensation;
2013 LL.M., University of New South Wales, Australia
2010 Admission to the Swiss bar
2007 Master of Law with additional degree in European Community Law, University of Fribourg
2006 Bachelor of Law, University of Fribourg
Best Lawyers 2024
The Legal500 EMEA 2023 – Recommended
IP Stars 2023 – Notable Practitioner – Switzerland
IFLR Rising Stars Awards EMEA 2022 – Product Liability
The Legal500 EMEA 2022 – Recommended
IP Stars 2022 – Notable Practitioner – Switzerland
Who’s Who Legal: Thought Leaders – Switzerland 2022
Who’s Who Legal: Global 2022
Who’s Who Legal: Switzerland 2022
Lexology Client Choice Awards 2021 – Life Sciences Switzerland
Expert Guides – Rising Stars 2021
IP Stars 2021 – Notable Practitioner – Switzerland
The Legal500 EMEA 2021 – Recommended
Who’s Who Legal: Global 2021
Who’s Who Legal: Switzerland 2021
Expert Guides – Rising Stars 2020
Who’s Who Legal: Global 2020
  • Association Internationale des Jeunes Avocats (AIJA), President of the Healthcare and Life Sciences Commission, former National Representative for Switzerland and former Vice-President of the T.R.A.D.E. (Trade, Retail, Agency, Distribution, E-Commerce) Commission
  • ASA below 40
  • International Distribution Institute (IDI)
  • Licensing Executives Society (LES)
  • Swiss Bar Association
  • Zurich Bar Association
2020 Counsel, Niederer Kraft Frey
2017 Senior Associate at a major Swiss law firm in Zurich
2011 Associate at a major Swiss law firm in Zurich
2009 Law Clerk at the District Court of Zurich, Zurich
2008 Trainee at the District Court of Zurich, Zurich
2007 Junior Associate at a major Swiss law firm, Zurich





Deals & Cases


EMZ sells ASSEPRO group to The Ardonagh Group

Discover More

Lakera secures USD 10m in funding to secure Generative AI in the enterprise

Discover More

IDAK Food Group acquires Romer’s Hausbäckerei AG

Discover More

Market Perception

«Janine Reudt-Demont is an outstanding specialist of life sciences and healthcare law. She is still young, but she is very engaged, provides clear advice and is very active as a speaker and author.»
Legal 500 2022
«Janine Reudt-Demont is highly regarded for her top-notch work on distribution contracts for big-name clients in the life sciences sector.»
Who’s Who Legal 2022
«She has advised us very well on several complex life sciences regulatory and contractual matters. It is very rare for a law firm to have such a level of life science expertise, most often such people like Reudt-Demont would work in-house or as the regulator.»
Chambers 2022
«She is a highly skilled and responsive lawyer. She is a strong pillar for the firm.»
Chambers 2022



Praktische Umsetzungsschritte für das revidierte Datenschutzgesetz

Discover More

Practical Implementation Steps for Revised Swiss Data Protection Act

Discover More

Praktische Umsetzungsschritte für das revidierte Datenschutzgesetz

Discover More

Awards & Rankings


NKF recognised as highly recommended firm for IP Transactions by IP Stars 2023 – Switzerland

Discover More

Twelve NKF lawyers listed as “Thought Leaders Switzerland 2022” by Who’s Who Legal

Discover More

Five NKF lawyers recognised as Rising Stars at the IFLR Rising Stars Awards EMEA 2022

Discover More

Firm News


NKF represented with three lawyers in the AIJA Committee

Discover More

NKF lawyers Moritz Maurer and Janine Reudt-Demont take up president roles at AIJA

Discover More

NKF counsel Janine Reudt-Demont appointed as Swiss National Representative of AIJA

Discover More

In the Media


The change in the legal profession

Discover More

Expansion of NKF’s Technology and Data Law Practice

Discover More



The Healthcare Law Review: Switzerland

Discover More

Speaking Engagements


Revidiertes Schweizer Datenschutzgesetz

Discover More

Die DSG Revision und weitere relevante Entwicklungen im Datenschutz – was Sie für 2021 wissen m…

Discover More

Bearbeiten von Patientendaten in Zeiten von COVID-19 aus Sicht der Gesundheitsbranche – Was ist zu b…

Discover More

Newsletters & Alerts


Specific Amendments and Measures under the revised FADP – Risk-based-Approach in Light of the ne…

Discover More

New Standard Contractual Clauses for International Data Transfers

Discover More

Revised Federal Act on Data protection

Discover More